The nationwide Finnish anticoagulation in atrial fibrillation (FinACAF): study rationale, design, and patient characteristics
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The nationwide Finnish anticoagulation in atrial fibrillation (FinACAF): study rationale, design, and patient characteristics
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF EPIDEMIOLOGY
Volume 37, Issue 1, Pages 95-102
Publisher
Springer Science and Business Media LLC
Online
2022-01-05
DOI
10.1007/s10654-021-00812-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence and incidence rates of atrial fibrillation in Norway 2004–2014
- (2020) Lars Jøran Kjerpeseth et al. HEART
- Trends in Cardiovascular Disease Prevalence by Income Level in the United States
- (2020) Salma M. Abdalla et al. JAMA Network Open
- Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals
- (2019) Nicole Lowres et al. PLOS MEDICINE
- Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study
- (2018) Laila Staerk et al. BMJ-British Medical Journal
- Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study
- (2018) Laila Staerk et al. BMJ-British Medical Journal
- Association between Socio-Economic Status and Incident Atrial Fibrillation
- (2018) Satish Ramkumar et al. INTERNAL MEDICINE JOURNAL
- Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation: results from the nationwide FinWAF Registry
- (2017) Mika Lehto et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care
- (2017) Deirdre A. Lane et al. Journal of the American Heart Association
- Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project
- (2016) Wen-Hua Li et al. CLINICAL CARDIOLOGY
- Shape of the association between income and mortality: a cohort study of Denmark, Finland, Norway and Sweden in 1995 and 2003
- (2016) Laust H Mortensen et al. BMJ Open
- Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
- (2016) Xiaoxi Yao et al. Journal of the American Heart Association
- When the entire population is the sample: strengths and limitations in register-based epidemiology
- (2014) Lau Caspar Thygesen et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Warfarin treatment among Finnish patients with atrial fibrillation: retrospective registry study based on primary healthcare data
- (2014) Taru Hallinen et al. BMJ Open
- Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060
- (2013) B. P. Krijthe et al. EUROPEAN HEART JOURNAL
- Atrial fibrillation prevalence revisited
- (2013) L. Friberg et al. JOURNAL OF INTERNAL MEDICINE
- Quality of the Finnish Hospital Discharge Register: A systematic review
- (2012) Reijo Sund SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started